ScienceNew Pancreatic Cancer Pill Nearly Doubles Survival in 500-Patient TrialA once-daily pill called daraxonrasib pushed median survival from 6.7 to 13.2 months in advanced pancreatic cancer — the first real breakthrough in a disease long called "undruggable."
TechnologyA Lab Mistake at Cambridge Leads to a Breakthrough That Could Revolutionize Drug DevelopmentCambridge scientists accidentally discovered a light-powered chemical reaction that lets researchers modify complex drug molecules in minutes instead of months — without toxic chemicals.
